GT Biopharma, Inc

Abbott Diabetes Care, located in Alameda, Calif., designs, develops and manufactures several glucose monitoring systems and test strips for use in both home and hospital settings. Among its brands are FreeStyle, FreeStyle Flash, Precision Xtra and Precision PCx. Abbott entered the blood glucose monitoring marketplace with the acquisition of MediSense in 1996. In 2004, the company acquired TheraSense, a leader in developing blood glucose self-monitoring devices that require very small blood samples to deliver rapid test results. ADC is a subsidiary of Abbott Laboratories, a global health care company devoted to the discovery of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.

Founded in 1984, Kensey Nash Corporation is a medical technology company that develops and manufactures absorbable biomaterials-based products with applications in the cardiology, orthopedics, spine, drug and biologics delivery, periodontal/dental, surgical and wound-care markets. Its flagship product, the Angio-Seal vascular closure device, is designed to seal and close femoral artery punctures made during diagnostic and therapeutic cardiovascular catheterizations. The company also markets its proprietary TriActiv embolic protection system, a device designed to prevent microparticulates from traveling downstream during the treatment of diseased coronary saphenous vein bypass grafts. This system utilizes active flushing and extraction to remove debris from the vessel after a treatment procedure. The company also develops various bone graft substitutes fabricated from collagen, synthetic polymers and composite biomaterials. Kensey Nash Corporation maintains its United States headquarters in Exton, Penn., and its European headquarters in Germany.

Founded in 1997, BioCheck develops, manufactures and distributes immunodiagnostic test kits and research reagents. The company has a more than 15,000-square-foot manufacturing facility. It delivers products in Central America, Europe and Asia. BioCheck serves the health care, biomedical, pharmaceutical and scientific research markets. The company also offers antibody conjugation and purification services. Its skilled technicians have experience in microtiter plate coating. The company performs custom immunoassay development for osteoporosis, heart disease, and colorectal and breast cancer. It provides rabbit monoclonal antibodies for research applications with mouse and human Id1, Id2, Id3 and Id4 proteins. The company has received ISO 13485 certification from the International Organization for Standardization. BioCheck additionally offers multiple packaging options.